Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.240
+0.160 (5.19%)
At close: Aug 13, 2025, 4:00 PM
3.280
+0.040 (1.23%)
After-hours: Aug 13, 2025, 6:47 PM EDT
Bionano Genomics Employees
As of December 31, 2024, Bionano Genomics had 100 total employees, including 98 full-time and 2 part-time employees. The number of employees decreased by 244 or -70.93% compared to the previous year.
Employees
100
Change (1Y)
-244
Growth (1Y)
-70.93%
Revenue / Employee
$284,640
Profits / Employee
-$836,970
Market Cap
10.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BNGO News
- 6 days ago - Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL - GlobeNewsWire
- 7 days ago - Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 13 days ago - Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 - GlobeNewsWire
- 3 months ago - Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - GlobeNewsWire
- 3 months ago - Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - GlobeNewsWire
- 3 months ago - Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - GlobeNewsWire
- 3 months ago - Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - GlobeNewsWire